nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—BCL2—polycystic ovary syndrome	0.87	1	CbGaD
Rasagiline—CYP1A2—urine—polycystic ovary syndrome	0.00439	0.144	CbGeAlD
Rasagiline—BCL2—endometrium—polycystic ovary syndrome	0.0035	0.115	CbGeAlD
Rasagiline—BCL2—uterus—polycystic ovary syndrome	0.00323	0.106	CbGeAlD
Rasagiline—BCL2—female gonad—polycystic ovary syndrome	0.00264	0.0869	CbGeAlD
Rasagiline—BCL2—endocrine gland—polycystic ovary syndrome	0.00246	0.0808	CbGeAlD
Rasagiline—MAOB—embryo—polycystic ovary syndrome	0.00199	0.0656	CbGeAlD
Rasagiline—MAOB—adrenal cortex—polycystic ovary syndrome	0.00163	0.0537	CbGeAlD
Rasagiline—MAOB—endometrium—polycystic ovary syndrome	0.00146	0.048	CbGeAlD
Rasagiline—MAOB—uterus—polycystic ovary syndrome	0.00134	0.0442	CbGeAlD
Rasagiline—MAOB—pituitary gland—polycystic ovary syndrome	0.00132	0.0434	CbGeAlD
Rasagiline—MAOB—adipose tissue—polycystic ovary syndrome	0.00131	0.0432	CbGeAlD
Rasagiline—BCL2—Estrogen signaling pathway—GNAS—polycystic ovary syndrome	0.00123	0.0158	CbGpPWpGaD
Rasagiline—MAOB—Alpha-synuclein signaling—TH—polycystic ovary syndrome	0.00122	0.0156	CbGpPWpGaD
Rasagiline—MAOB—adrenal gland—polycystic ovary syndrome	0.00118	0.0388	CbGeAlD
Rasagiline—BCL2—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00115	0.0147	CbGpPWpGaD
Rasagiline—BCL2—Activation of BAD and translocation to mitochondria—AKT2—polycystic ovary syndrome	0.00112	0.0143	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—LMNA—polycystic ovary syndrome	0.00111	0.0142	CbGpPWpGaD
Rasagiline—MAOB—female gonad—polycystic ovary syndrome	0.0011	0.0362	CbGeAlD
Rasagiline—MAOB—vagina—polycystic ovary syndrome	0.00109	0.0359	CbGeAlD
Rasagiline—BCL2—Corticotropin-releasing hormone—STAR—polycystic ovary syndrome	0.00103	0.0132	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—GAB1—polycystic ovary syndrome	0.00103	0.0132	CbGpPWpGaD
Rasagiline—MAOB—endocrine gland—polycystic ovary syndrome	0.00102	0.0336	CbGeAlD
Rasagiline—Accidental injury—Metformin—polycystic ovary syndrome	0.000968	0.0437	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—LIF—polycystic ovary syndrome	0.000931	0.012	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—ATF1—polycystic ovary syndrome	0.000908	0.0117	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—ATF1—polycystic ovary syndrome	0.000908	0.0117	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—HSD3B1—polycystic ovary syndrome	0.000876	0.0112	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—LMNA—polycystic ovary syndrome	0.000868	0.0111	CbGpPWpGaD
Rasagiline—MAOB—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000813	0.0104	CbGpPWpGaD
Rasagiline—Neuropathy—Metformin—polycystic ovary syndrome	0.000804	0.0363	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—HSD3B2—polycystic ovary syndrome	0.000781	0.01	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNFSF10—polycystic ovary syndrome	0.000764	0.00981	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—BAX—polycystic ovary syndrome	0.000762	0.00979	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—BAX—polycystic ovary syndrome	0.000762	0.00979	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—PPARG—polycystic ovary syndrome	0.000759	0.00975	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—TAB1—polycystic ovary syndrome	0.000756	0.00971	CbGpPWpGaD
Rasagiline—BCL2—EPO signaling pathway—IRS2—polycystic ovary syndrome	0.000755	0.00969	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—AKT2—polycystic ovary syndrome	0.000743	0.00954	CbGpPWpGaD
Rasagiline—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000728	0.0239	CbGeAlD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000724	0.00929	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—TH—polycystic ovary syndrome	0.000707	0.00908	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—SULT2A1—polycystic ovary syndrome	0.000696	0.00893	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—BAX—polycystic ovary syndrome	0.000678	0.0087	CbGpPWpGaD
Rasagiline—Injury—Metformin—polycystic ovary syndrome	0.000677	0.0306	CcSEcCtD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000673	0.00864	CbGpPWpGaD
Rasagiline—MAOB—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000655	0.00841	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—BAX—polycystic ovary syndrome	0.000632	0.00812	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CYP11A1—polycystic ovary syndrome	0.000616	0.00791	CbGpPWpGaD
Rasagiline—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000614	0.00789	CbGpPWpGaD
Rasagiline—Migraine—Metformin—polycystic ovary syndrome	0.000612	0.0276	CcSEcCtD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—BAX—polycystic ovary syndrome	0.000575	0.00739	CbGpPWpGaD
Rasagiline—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000574	0.0259	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNFSF10—polycystic ovary syndrome	0.00056	0.00719	CbGpPWpGaD
Rasagiline—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000559	0.00718	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—BAX—polycystic ovary syndrome	0.000551	0.00707	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.000549	0.00705	CbGpPWpGaD
Rasagiline—CYP1A2—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00054	0.00694	CbGpPWpGaD
Rasagiline—Influenza—Metformin—polycystic ovary syndrome	0.000537	0.0243	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—INSR—polycystic ovary syndrome	0.000535	0.00687	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000533	0.00684	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—AKT2—polycystic ovary syndrome	0.000531	0.00682	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TNFSF10—polycystic ovary syndrome	0.000525	0.00675	CbGpPWpGaD
Rasagiline—Angina pectoris—Metformin—polycystic ovary syndrome	0.000524	0.0236	CcSEcCtD
Rasagiline—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0005	0.0226	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.000499	0.00641	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—IRS2—polycystic ovary syndrome	0.000497	0.00637	CbGpPWpGaD
Rasagiline—Infestation—Metformin—polycystic ovary syndrome	0.000479	0.0216	CcSEcCtD
Rasagiline—Infestation NOS—Metformin—polycystic ovary syndrome	0.000479	0.0216	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—PLAT—polycystic ovary syndrome	0.000474	0.00609	CbGpPWpGaD
Rasagiline—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00047	0.0212	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000456	0.00586	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—IGF1—polycystic ovary syndrome	0.000441	0.00566	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000434	0.00557	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—IRS1—polycystic ovary syndrome	0.000433	0.00556	CbGpPWpGaD
Rasagiline—Rhinitis—Metformin—polycystic ovary syndrome	0.000431	0.0195	CcSEcCtD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000429	0.00551	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TCF7L2—polycystic ovary syndrome	0.000428	0.0055	CbGpPWpGaD
Rasagiline—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000428	0.0193	CcSEcCtD
Rasagiline—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000424	0.0191	CcSEcCtD
Rasagiline—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000423	0.0191	CcSEcCtD
Rasagiline—BCL2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.000418	0.00537	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000417	0.00535	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.000415	0.00532	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—GNAS—polycystic ovary syndrome	0.000405	0.0052	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—BAX—polycystic ovary syndrome	0.000404	0.00519	CbGpPWpGaD
Rasagiline—Eye disorder—Metformin—polycystic ovary syndrome	0.000402	0.0182	CcSEcCtD
Rasagiline—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000399	0.018	CcSEcCtD
Rasagiline—Angiopathy—Metformin—polycystic ovary syndrome	0.00039	0.0176	CcSEcCtD
Rasagiline—BCL2—Apoptosis—LMNA—polycystic ovary syndrome	0.00039	0.005	CbGpPWpGaD
Rasagiline—Immune system disorder—Metformin—polycystic ovary syndrome	0.000389	0.0175	CcSEcCtD
Rasagiline—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000388	0.0175	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—IL18—polycystic ovary syndrome	0.000387	0.00497	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—INS—polycystic ovary syndrome	0.000387	0.00496	CbGpPWpGaD
Rasagiline—Chills—Metformin—polycystic ovary syndrome	0.000386	0.0174	CcSEcCtD
Rasagiline—MAOB—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000385	0.00494	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—BAX—polycystic ovary syndrome	0.000379	0.00487	CbGpPWpGaD
Rasagiline—Malnutrition—Metformin—polycystic ovary syndrome	0.000375	0.0169	CcSEcCtD
Rasagiline—Flatulence—Metformin—polycystic ovary syndrome	0.000369	0.0167	CcSEcCtD
Rasagiline—Dysgeusia—Metformin—polycystic ovary syndrome	0.000367	0.0166	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—CCNB1—polycystic ovary syndrome	0.000365	0.00469	CbGpPWpGaD
Rasagiline—Muscle spasms—Metformin—polycystic ovary syndrome	0.00036	0.0163	CcSEcCtD
Rasagiline—MAOB—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000358	0.00459	CbGpPWpGaD
Rasagiline—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000353	0.00453	CbGpPWpGaD
Rasagiline—Tremor—Metformin—polycystic ovary syndrome	0.000351	0.0158	CcSEcCtD
Rasagiline—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000347	0.0157	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNFSF10—polycystic ovary syndrome	0.000343	0.00441	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000338	0.00434	CbGpPWpGaD
Rasagiline—Malaise—Metformin—polycystic ovary syndrome	0.000338	0.0153	CcSEcCtD
Rasagiline—Syncope—Metformin—polycystic ovary syndrome	0.000336	0.0152	CcSEcCtD
Rasagiline—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000329	0.0149	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—BAX—polycystic ovary syndrome	0.000328	0.00421	CbGpPWpGaD
Rasagiline—Hypertension—Metformin—polycystic ovary syndrome	0.000323	0.0146	CcSEcCtD
Rasagiline—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000321	0.00412	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00032	0.00411	CbGpPWpGaD
Rasagiline—Chest pain—Metformin—polycystic ovary syndrome	0.000319	0.0144	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000317	0.0143	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000316	0.00406	CbGpPWpGaD
Rasagiline—Discomfort—Metformin—polycystic ovary syndrome	0.000315	0.0142	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000312	0.00401	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000305	0.00392	CbGpPWpGaD
Rasagiline—Infection—Metformin—polycystic ovary syndrome	0.000304	0.0137	CcSEcCtD
Rasagiline—Shock—Metformin—polycystic ovary syndrome	0.000301	0.0136	CcSEcCtD
Rasagiline—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0003	0.0135	CcSEcCtD
Rasagiline—Skin disorder—Metformin—polycystic ovary syndrome	0.000297	0.0134	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000297	0.00381	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.000296	0.0038	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000295	0.0133	CcSEcCtD
Rasagiline—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000295	0.00379	CbGpPWpGaD
Rasagiline—Anorexia—Metformin—polycystic ovary syndrome	0.000291	0.0132	CcSEcCtD
Rasagiline—Hypotension—Metformin—polycystic ovary syndrome	0.000286	0.0129	CcSEcCtD
Rasagiline—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000284	0.00364	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000283	0.00363	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—IGF1—polycystic ovary syndrome	0.000282	0.00362	CbGpPWpGaD
Rasagiline—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000278	0.0126	CcSEcCtD
Rasagiline—Paraesthesia—Metformin—polycystic ovary syndrome	0.000274	0.0124	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—POMC—polycystic ovary syndrome	0.000273	0.0035	CbGpPWpGaD
Rasagiline—Dyspnoea—Metformin—polycystic ovary syndrome	0.000272	0.0123	CcSEcCtD
Rasagiline—Somnolence—Metformin—polycystic ovary syndrome	0.000272	0.0123	CcSEcCtD
Rasagiline—Dyspepsia—Metformin—polycystic ovary syndrome	0.000269	0.0122	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—BAX—polycystic ovary syndrome	0.000269	0.00345	CbGpPWpGaD
Rasagiline—Decreased appetite—Metformin—polycystic ovary syndrome	0.000266	0.012	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000264	0.0119	CcSEcCtD
Rasagiline—Constipation—Metformin—polycystic ovary syndrome	0.000261	0.0118	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000253	0.00325	CbGpPWpGaD
Rasagiline—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000252	0.0114	CcSEcCtD
Rasagiline—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00025	0.0113	CcSEcCtD
Rasagiline—BCL2—Apoptosis—BAX—polycystic ovary syndrome	0.000248	0.00318	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—IRS1—polycystic ovary syndrome	0.000247	0.00317	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000246	0.00316	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—INS—polycystic ovary syndrome	0.000244	0.00313	CbGpPWpGaD
Rasagiline—Urticaria—Metformin—polycystic ovary syndrome	0.000243	0.011	CcSEcCtD
Rasagiline—Abdominal pain—Metformin—polycystic ovary syndrome	0.000242	0.0109	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IGF1—polycystic ovary syndrome	0.000236	0.00303	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT2—polycystic ovary syndrome	0.000229	0.00294	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000228	0.00293	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000226	0.0029	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—SERPINE1—polycystic ovary syndrome	0.000224	0.00288	CbGpPWpGaD
Rasagiline—Asthenia—Metformin—polycystic ovary syndrome	0.000219	0.0099	CcSEcCtD
Rasagiline—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000219	0.00281	CbGpPWpGaD
Rasagiline—Pruritus—Metformin—polycystic ovary syndrome	0.000216	0.00977	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000209	0.00269	CbGpPWpGaD
Rasagiline—Diarrhoea—Metformin—polycystic ovary syndrome	0.000209	0.00944	CcSEcCtD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000207	0.00265	CbGpPWpGaD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000204	0.00262	CbGpPWpGaD
Rasagiline—Dizziness—Metformin—polycystic ovary syndrome	0.000202	0.00913	CcSEcCtD
Rasagiline—MAOB—Metabolism—NMNAT3—polycystic ovary syndrome	0.000201	0.00258	CbGpPWpGaD
Rasagiline—Vomiting—Metformin—polycystic ovary syndrome	0.000194	0.00878	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000194	0.00249	CbGpPWpGaD
Rasagiline—Rash—Metformin—polycystic ovary syndrome	0.000193	0.0087	CcSEcCtD
Rasagiline—Dermatitis—Metformin—polycystic ovary syndrome	0.000193	0.00869	CcSEcCtD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000192	0.00247	CbGpPWpGaD
Rasagiline—Headache—Metformin—polycystic ovary syndrome	0.000191	0.00865	CcSEcCtD
Rasagiline—BCL2—Immune System—FBXO44—polycystic ovary syndrome	0.000191	0.00245	CbGpPWpGaD
Rasagiline—BCL2—Immune System—UBE2H—polycystic ovary syndrome	0.000191	0.00245	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.00019	0.00244	CbGpPWpGaD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00019	0.00243	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000188	0.00241	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SUOX—polycystic ovary syndrome	0.000184	0.00236	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LPCAT2—polycystic ovary syndrome	0.000184	0.00236	CbGpPWpGaD
Rasagiline—Nausea—Metformin—polycystic ovary syndrome	0.000182	0.0082	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—SERPINE1—polycystic ovary syndrome	0.000178	0.00228	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT2—polycystic ovary syndrome	0.000173	0.00222	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.000172	0.0022	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ISYNA1—polycystic ovary syndrome	0.000171	0.00219	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—POMC—polycystic ovary syndrome	0.00017	0.00218	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	0.000169	0.00217	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000168	0.00215	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FGF18—polycystic ovary syndrome	0.000162	0.00207	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PTAFR—polycystic ovary syndrome	0.000157	0.00202	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.000156	0.002	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000156	0.002	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000152	0.00195	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.000152	0.00195	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000152	0.00195	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000152	0.00195	CbGpPWpGaD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00015	0.00193	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—GAB1—polycystic ovary syndrome	0.000147	0.00189	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—IGF1—polycystic ovary syndrome	0.000147	0.00188	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—AKT2—polycystic ovary syndrome	0.000147	0.00188	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000146	0.00188	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000146	0.00187	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKR1C2—polycystic ovary syndrome	0.000145	0.00186	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TEAD2—polycystic ovary syndrome	0.000145	0.00186	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.000142	0.00182	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TNRC6B—polycystic ovary syndrome	0.000132	0.00169	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000123	0.00158	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000123	0.00157	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PNPLA2—polycystic ovary syndrome	0.000122	0.00156	CbGpPWpGaD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000121	0.00155	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ATF1—polycystic ovary syndrome	0.000116	0.00149	CbGpPWpGaD
Rasagiline—BCL2—Immune System—RACGAP1—polycystic ovary syndrome	0.000116	0.00149	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000115	0.00148	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000115	0.00148	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—STAR—polycystic ovary syndrome	0.00011	0.00141	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000108	0.00138	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TAB1—polycystic ovary syndrome	0.000107	0.00137	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—polycystic ovary syndrome	0.000107	0.00137	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.0001	0.00129	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	9.94e-05	0.00128	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	9.91e-05	0.00127	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HMMR—polycystic ovary syndrome	9.8e-05	0.00126	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—VEGFA—polycystic ovary syndrome	9.59e-05	0.00123	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	9.55e-05	0.00123	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	9.54e-05	0.00122	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FGF18—polycystic ovary syndrome	9.41e-05	0.00121	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HSD3B1—polycystic ovary syndrome	9.35e-05	0.0012	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	9.14e-05	0.00117	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.9e-05	0.00114	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.78e-05	0.00113	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NRG1—polycystic ovary syndrome	8.71e-05	0.00112	CbGpPWpGaD
Rasagiline—BCL2—Immune System—GAB1—polycystic ovary syndrome	8.59e-05	0.0011	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LHB—polycystic ovary syndrome	8.52e-05	0.00109	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HSD3B2—polycystic ovary syndrome	8.33e-05	0.00107	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	8.29e-05	0.00106	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	8.27e-05	0.00106	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	8.16e-05	0.00105	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKR1C1—polycystic ovary syndrome	8.07e-05	0.00104	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CAMK2D—polycystic ovary syndrome	7.8e-05	0.001	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TNRC6B—polycystic ovary syndrome	7.68e-05	0.000986	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	7.54e-05	0.000968	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	7.54e-05	0.000968	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IRS2—polycystic ovary syndrome	7.46e-05	0.000958	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CRP—polycystic ovary syndrome	7.46e-05	0.000958	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SULT2A1—polycystic ovary syndrome	7.43e-05	0.000953	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	7.41e-05	0.000951	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—RRM2—polycystic ovary syndrome	7.19e-05	0.000923	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	7.1e-05	0.000912	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—YAP1—polycystic ovary syndrome	6.93e-05	0.00089	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ATF1—polycystic ovary syndrome	6.75e-05	0.000866	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NAMPT—polycystic ovary syndrome	6.66e-05	0.000855	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP11A1—polycystic ovary syndrome	6.58e-05	0.000844	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.55e-05	0.000841	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IRS1—polycystic ovary syndrome	6.51e-05	0.000836	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.46e-05	0.000829	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	6.32e-05	0.000811	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TAB1—polycystic ovary syndrome	6.22e-05	0.000799	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKR1C3—polycystic ovary syndrome	6.21e-05	0.000797	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRL—polycystic ovary syndrome	6.17e-05	0.000792	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP17A1—polycystic ovary syndrome	6.11e-05	0.000785	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT2—polycystic ovary syndrome	6.03e-05	0.000774	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	5.99e-05	0.000769	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	5.71e-05	0.000733	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TH—polycystic ovary syndrome	5.29e-05	0.000679	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	5.28e-05	0.000678	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.21e-05	0.000668	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL18—polycystic ovary syndrome	5.19e-05	0.000666	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC2A4—polycystic ovary syndrome	5.15e-05	0.000661	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NRG1—polycystic ovary syndrome	5.07e-05	0.000651	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	4.86e-05	0.000624	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP19A1—polycystic ovary syndrome	4.84e-05	0.000621	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	4.64e-05	0.000596	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	4.43e-05	0.000569	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IRS2—polycystic ovary syndrome	4.35e-05	0.000558	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—polycystic ovary syndrome	4.35e-05	0.000558	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	4.33e-05	0.000556	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GNAS—polycystic ovary syndrome	4.32e-05	0.000554	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	4.25e-05	0.000545	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	4.25e-05	0.000545	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.19e-05	0.000538	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NCOR1—polycystic ovary syndrome	4.11e-05	0.000528	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	3.95e-05	0.000507	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	3.94e-05	0.000505	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP1A1—polycystic ovary syndrome	3.9e-05	0.000501	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	3.86e-05	0.000495	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IRS1—polycystic ovary syndrome	3.79e-05	0.000487	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MTHFR—polycystic ovary syndrome	3.64e-05	0.000467	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.6e-05	0.000462	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT2—polycystic ovary syndrome	3.51e-05	0.000451	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.42e-05	0.000439	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	3.36e-05	0.000431	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	3.36e-05	0.000431	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.23e-05	0.000414	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.18e-05	0.000408	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARG—polycystic ovary syndrome	2.95e-05	0.000379	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—POMC—polycystic ovary syndrome	2.91e-05	0.000373	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—INS—polycystic ovary syndrome	2.89e-05	0.000371	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	2.81e-05	0.000361	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—polycystic ovary syndrome	2.73e-05	0.00035	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	2.67e-05	0.000342	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	2.54e-05	0.000327	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.51e-05	0.000323	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	2.27e-05	0.000291	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.16e-05	0.000278	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.14e-05	0.000274	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.03e-05	0.00026	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.97e-05	0.000253	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.93e-05	0.000247	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.87e-05	0.00024	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.72e-05	0.000221	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	1.66e-05	0.000214	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.6e-05	0.000206	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—polycystic ovary syndrome	1.59e-05	0.000204	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.54e-05	0.000198	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.53e-05	0.000197	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.52e-05	0.000195	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.51e-05	0.000194	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.44e-05	0.000185	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.42e-05	0.000182	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.22e-05	0.000157	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.19e-05	0.000153	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.12e-05	0.000144	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1e-05	0.000128	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	9.52e-06	0.000122	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	9.03e-06	0.000116	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	8.42e-06	0.000108	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	6.82e-06	8.76e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	6.73e-06	8.64e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—INS—polycystic ovary syndrome	6.69e-06	8.59e-05	CbGpPWpGaD
